Poor adherence to AASLD guidelines for chronic hepatitis b management and treatment in a large academic medical center

American Journal of Gastroenterology

Volumn 109, Issue 6, 2014, Pages 867-875

  Wu, Ying ^a   Johnson, Kara B ^a   Roccaro, Giorgio ^a   Lopez, Joanna ^a   Zheng, Hui ^a   Muiru, Anthony ^a   Ufere, Nneka ^a   Rajbhandari, Ruma ^a   Kattan, Omar ^a   Chung, Raymond T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER SCREENING; CHRONIC HEPATITIS B; CLINICAL DECISION MAKING; DEMOGRAPHY; FEMALE; FOLLOW UP; GASTROENTEROLOGIST; GASTROENTEROLOGY; GENERAL PRACTITIONER; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LIVER BIOPSY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIXED INFECTION; PATIENT CARE; PATIENT MONITORING; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT REFUSAL; UNIVERSITY HOSPITAL; VIRUS IMMUNITY; VIRUS LOAD;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; BIOPSY; DNA, VIRAL; FEMALE; GUIDELINE ADHERENCE; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES;

EID: 84902083565     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.72     Document Type: Article

References (25)

1. Cohen C, Holmberg SD, McMahon BJ, et al. Is chronic hepatitis B being undertreated in the United States?. J Viral Hepat 2011;18;377-83
2. Lok AS, McMahon BJ. Chronic hepatitis B: Update 2009. Hepatology 2009;50;661-2
3. Institute of Medicine. Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. The National Academies Press, Washington, DC, 2010
4. Tong MJ, Hsu L, Chang PW, et al. Evaluation of current treatment recommendations for chronic hepatitis B: A 2011 update. J Gastroenterol Hepatol 2011;26;829-35
5. Juday T, Tang H, Harris M, et al. Adherence to chronic hepatitis B treatment guideline recommendations for laboratory monitoring of patients who are not receiving antiviral treatment. J Gen Intern Med 2011;26;239-44
6. Wong CR, Garcia RT, Trinh HN, et al. Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting. Dig Dis Sci 2009;54;2712-21
7. Zhang S, Ristau JT, Trinh HN, et al. Undertreatment of Asian chronic hepatitis B patients on the basis of standard guidelines: A community-based study. Dig Dis Sci 2012;57;1373-83
8. Nalichowski R, Keogh D, Chueh HC, et al. Calculating the benefi ts of a research patient data repository. AMIA Annu Symp Proc 2006;1044
9. Iloeje UH, Yang HI, Su J, et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-In HBV (the REVEAL-HBV) Study Group. Gastroenterology 2006;130;678-86. (Pubitemid 43374518
10. Sanai FM, Helmy A, Bzeizi KI, et al. Discriminant value of serum HBV DNA levels as predictors of liver fi brosis in chronic hepatitis B. J Viral Hepat 2011;18;e217-25
11. Papatheodoridis GV, Manesis EK, Manolakopoulos S, et al. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?. Hepatology 2008;48;1451-9
12. Kumar M, Sarin SK, Hissar S, et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 2008;134;1376-84. (Pubitemid 351615375
13. Sanai FM, Babatin MA, Bzeizi KI, et al. Accuracy of international guidelines for identifying signifi cant fi brosis in hepatitis B e antigen-negative patients with chronic hepatitis. Clin Gastroenterol Hepatol 2013;11;1493-1499.e2
14. Papatheodoridis GV, Manolakopoulos S, Liaw YF, et al. Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: A systematic review. J Hepatol 2012;57;196-202
15. Veldhuijzen IK, Toy M, HahnéSJ, et al. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-eff ective. Gastroenterology 2010;138;522-30
16. Jung CW, Tan J, Tan N, et al. Evidence for the insuffi cient evaluation and undertreatment of chronic hepatitis B infection in a predominantly lowincome and immigrant population. J Gastroenterol Hepatol 2010;25;369-75
17. Pramoolsinsap C, Poovorawan Y, Hirsch P, et al. Acute, hepatitis-A superinfection in HBV carriers, or chronic liver disease related to HBV or HCV. Ann Trop Med Parasitol 1999;93;745-51. (Pubitemid 29527697
18. Nguyen TT, Gildengorin G, Truong A, et al. Factors infl uencing physicians ' screening behavior for liver cancer among high-risk patients. J Gen Intern Med 2007;22;523-6. (Pubitemid 46941211
19. Khalili M, Guy J, Yu A, et al. Hepatitis B and hepatocellular carcinoma screening among Asian Americans: Survey of safety net healthcare providers. Dig Dis Sci 2011;56;1516-23
20. Mayorga CA, Rockey DC. Clinical utility of a standardized electronic order set for the management of acute upper gastrointestinal hemorrhage in patients with cirrhosis. Clin Gastroenterol Hepatol 2013;11;1342-8
21. Malespin M, Wong S, Siqueira F, et al. Barriers to treatment of hepatitis B in an urban Chinatown community. J Clin Gastroenterol 2012;46;e66-70
22. Wiegand J, van B ö mmel F, Berg T. Management of chronic hepatitis B: Status and challenges beyond treatment guidelines. Semin Liver Dis 2010;30;361-77
23. Hu KQ. Hepatitis B virus (HBV) infection in Asian and Pacifi c Islander Americans (APIAs): How can we do better for this special population?. Am J Gastroenterol 2008;103;1824-33
24. Tan NC, Cheah SL. What barriers do primary care physicians face in the management of patients with chronic hepatitis B infection in primary care?. Singapore Med J 2005;46;333-9
25. Hwang JP, Roundtree AK, Engebretson JC, et al. Medical care of hepatitis B among Asian American populations: Perspectives from three provider groups. J Gen Intern Med 2010;25;220-7